Development of a high risk pancreatic screening clinic using 3.0 T MRIChad A. Barnes, Susan Tsai, Douglas B. Evans et al.|Familial Cancer|2017Cited by 28
Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice?Ashley N. Krepline, Susan Tsai, Lindsay A. Bliss et al.|Journal of Gastrointestinal Surgery|2019Cited by 9
Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancerAshley N. Krepline, Rebecca Y. Kim, Jennifer L. Geurts et al.|Surgery|2020Cited by 9
Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort LevelMichael T. Zimmermann, Raúl Urrutia, Angela Mathison et al.|Frontiers in Oncology|2021Cited by 6
Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancerAshley N. Krepline, Susan Tsai, Jennifer L. Geurts et al.|HPB|2020Cited by 3